Lyme Disease Cover Up?

Peater Piper

Member
Joined
Mar 18, 2016
Messages
817
The major problem is the lack of accurate Lyme tests. I had a case of acute Lyme several years ago, confirmed by erythema migrans (bull's-eye rash). A blood test on the day of diagnosis and another blood test several months later both came back negative for Lyme. I was fortunate to develop the rash, as not everyone does. Most doctors are not going to treat something they can't even diagnose with some certainty, and current testing for Lyme seems to be about as accurate as a coin flip. What I find most disturbing is the CDC's opinion that a short course of antibiotics is probably enough to eliminate the infection, when multiple animal studies have shown that current guidelines for treatment often do not eliminate the infection, with autopsies confirming the infection persists and invades vital organs.
 
OP
B

Braveheart

Guest
Insurance companies don't want accurate tests and they are in bed with CDC...They will continue to deny it, because if there’s one thing insurance companies hate, it’s chronic disorders they have to spend time and money treating. ...
 

Peater Piper

Member
Joined
Mar 18, 2016
Messages
817
It's possible better testing doesn't exist for those reasons, but I think the nature of borrelia burgdorferi makes them very hard to detect. They can live outside of the bloodstream, so they won't necessarily be present in a blood draw, and they can suppress and hide from the immune system, which means antibodies aren't a reliable test either. Until recently, many Lyme doctors would start a course of antibiotics based on symptoms and then retest after a month or so. Their hope was that the immune system would detect the dead borrelia burgdorferi and produce antibodies, which would then result in a positive test. At that point, they would know to continue with treatment.

Newer tests are being developed, which focus on metabolomics. Development of a metabolic biosignature for detection of early Lyme disease. - PubMed - NCBI There's also more doctors and scientists coming around to the idea that the initial course of antibiotics may not be effective in all people.

As tick season begins, researchers find promising treatment for Lyme-related disease
About 300,000 people a year are infected with Lyme disease through tick bites, and for up to 20 percent of them the condition persists after a course of antibiotics. But just in time for tick season, Johns Hopkins University researchers are now onto a promising treatment for those sufferers.

It would be the first specific treatment for those who contend with such symptoms as fatigue, muscle and joint aches, and brain fog, sometimes severe. It also would be a major step for researchers who long struggled to even prove those symptoms were related to Lyme — partly because Lyme bacteria was no longer detected in blood tests after the initial treatment.

Most cases of Lyme disease are resolved with a course of doxycycline, amoxicillin or cefuroxime, for two to four weeks.

Researchers from the Hopkins Bloomberg School of Public Health have had success in mice with a three-drug combination — daptomycin, doxycycline and ceftriaxone — to treat what is now called post-treatment Lyme disease syndrome. The new study was published in the March 28 journal Discovery Medicine.

The idea is that there is slow-growing variant of Lyme bacteria, Borrelia burgdorferi, which persists and causes these sometimes severe arthritis-like symptoms. The “persister” bacteria were found to be immune to the standard single-antibiotic treatment.

Researchers believe certain conditions cause these bacteria to switch from their normal fast-growth mode to variants with little or no growth.

Past studies also have suggested these variants can be killed with the right drugs.

The next step for the three-drug combination will be testing it in people.

“There is a lot of excitement in the field, because we now have not only a plausible explanation but also a potential solution for patients who suffer from persistent Lyme disease symptoms despite standard single-antibiotic treatment,” said Dr. Ying Zhang, the study’s senior author and a professor in the Bloomberg School’s department of molecular microbiology and immunology.

Zhang said the idea of drug combinations may translate to treatments for other infectious diseases caused by such persister bacteria.

Lyme doctors are already aware of the multi-drug approach against persisters, but still, the right choice of antibiotics is highly disputed, and some of them come with significant drawbacks. Co-infections complicate things even further, as they often need to be treated as well. More research is obviously needed. It would behoove insurance companies to get on board. The right treatment could prevent chronic cases, and cure cases that have become chronic. The alternative is misdiagnosis and wasted money on ineffective treatment.
 
OP
B

Braveheart

Guest
It's possible better testing doesn't exist for those reasons, but I think the nature of borrelia burgdorferi makes them very hard to detect. They can live outside of the bloodstream, so they won't necessarily be present in a blood draw, and they can suppress and hide from the immune system, which means antibodies aren't a reliable test either. Until recently, many Lyme doctors would start a course of antibiotics based on symptoms and then retest after a month or so. Their hope was that the immune system would detect the dead borrelia burgdorferi and produce antibodies, which would then result in a positive test. At that point, they would know to continue with treatment.

Newer tests are being developed, which focus on metabolomics. Development of a metabolic biosignature for detection of early Lyme disease. - PubMed - NCBI There's also more doctors and scientists coming around to the idea that the initial course of antibiotics may not be effective in all people.

As tick season begins, researchers find promising treatment for Lyme-related disease


Lyme doctors are already aware of the multi-drug approach against persisters, but still, the right choice of antibiotics is highly disputed, and some of them come with significant drawbacks. Co-infections complicate things even further, as they often need to be treated as well. More research is obviously needed. It would behoove insurance companies to get on board. The right treatment could prevent chronic cases, and cure cases that have become chronic. The alternative is misdiagnosis and wasted money on ineffective treatment.
Good information, many thanks!
 

TheGoogler

Member
Joined
May 11, 2017
Messages
51
I would expect Lyme to be so persistent, given it was a bioweapon made on Plum Island. The CDC annual reports show Lyme spreading West quite quickly in these past few years, and I expect that map to be quite innacurate given how underreported the disease is. Apart from its ability to slip past tests, most doctors aren't willing to seriously consider it before other things have been ruled out. As @bzmazu's article indicates, it is also an STD, something else that hasn't emerged in the public sentience yet. Here's a 15 minute video on the history of the disease if you're interested in learning more about its origins.
 

Nokoni

Member
Joined
Feb 18, 2017
Messages
695
Here's a well-written overview of Lyme Disease from the perspective of a patient: Lyme Disease Is Baffling, Even to Experts
It also includes this great comment from a doctor: "As the surgeon Atul Gawande once wrote of the medical profession, 'Nothing is more threatening to who you think you are than a patient with a problem you cannot solve.'"
 

boxers

Member
Joined
Mar 2, 2018
Messages
339
Treating lyme is difficult
I know of many people who literally spent 10k on lyme and never got any better, some even got worse...
 
Last edited:

Similar threads

Back
Top Bottom